Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Prins Cyclization Catalyzed by a Fe(III)/TMS System: the Oxocarbenium Ion Pathway versus the [2+2] Cycloaddition

  • Pérez, Sixto J.
  • Purino, Martín
  • Miranda, Pedro O.
  • Martín, Víctor S.
  • Fernández, Israel
  • Padrón, Juan I.
The different factors that control the alkene Prins cyclization catalyzed by iron(III) salts have been explored by means of a joint experimental–computational study. The iron(III) salt/trimethylsilyl halide system has proved to be an excellent promoter in the synthesis of crossed all‐cis disubstituted tetrahydropyrans, minimizing the formation of products derived from side‐chain exchange. In this iron(III)‐catalyzed Prins cyclization reaction between homoallylic alcohols and non‐activated alkenes, two mechanistic pathways can be envisaged, namely the classical oxocarbenium route and the alternative [2+2] cycloaddition‐based pathway. It is found that the [2+2] pathway is disfavored for those alcohols having non‐activated and non‐substituted alkenes. In these cases, the classical pathway, via the key oxocarbenium ion, is preferred. In addition, the final product distribution strongly depends upon the nature of the substituent adjacent to the hydroxy group in the homoallylic alcohol, which can favor or hamper a side 2‐oxonia‐Cope rearrangement., This research was supported by the Spanish MINECO, co‐financed by the European Regional Development Fund (ERDF) and FEDER (CTQ2011‐28417‐C02–01/BQU, , CTQ2011‐22653, CTQ2013‐44303‐P) and IMBRAIN project (FP7‐REGPOT‐2012‐CT2012‐31637‐IMBRAIN), funded under the 7th Framework Programme (CAPACITIES). S.J.P. thanks the Spanish MINECO for a F.P.U fellowship. The research leading to these results received funding from the People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007‐2013 under REA grant agreement no. 623155 to P.O.M)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthetic molecules for disruption of the MYC protein-protein interface

  • Jacob, Nicholas T.
  • Miranda, Pedro O.
  • Shirey, Ryan J.
  • Gautam, Ritika
  • Zhou, Bin
  • de Orbe Izquierdo, M.Elena
  • Hixon, Mark S.
  • Hart, Jonathan R.
  • Ueno, Lynn
  • Vogt, Peter K.
  • Janda, Kim D.
MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein level have been limited. Previously, we discovered 5a, that binds to MYC with potency and specificity, downregulates the transcriptional activities of MYC and shows efficacy in vivo. However, this scaffold posed intrinsic pharmacokinetic liabilities, namely, poor solubility that precluded biophysical interrogation. Here, we developed a screening platform based on field-effect transistor analysis (Bio-FET), surface plasmon resonance (SPR), and a microtumor formation assay to analyze a series of new compounds aimed at improving these properties. This blind SAR campaign has produced a new lead compound of significantly increased in vivo stability and solubility for a 40-fold increase in exposure. This probe represents a significant advancement that will not only enable biophysical characterization of this interaction and further SAR, but also contribute to advances in understanding of MYC biology., This work was supported by the Skaggs Institute for Chemical Biology, the National Institutes of Health (R35 CA197582 to P.K.V., and CTSA TL1TR002551 to N.T.J), and the Seventh Framework Program of the European Union (REA Grant Agreement No. 623155 to P.O.M.)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity

  • Miranda, Pedro O.
  • Cubitt, Beatrice
  • Jacob, Nicholas T.
  • Janda, Kim D.
  • De La Torre, Juan C.
Several arenaviruses cause hemorrhagic fever (HF) disease in humans and represent important public health problems in their endemic regions. In addition, evidence indicates that the worldwide-distributed prototypic arenavirus lymphocytic choriomeningitis virus is a neglected human pathogen of clinical significance. There are no licensed arenavirus vaccines, and current antiarenavirus therapy is limited to an off-label use of ribavirin that is only partially effective. Therefore, there is an unmet need for novel therapeutics to combat human pathogenic arenaviruses, a task that will be facilitated by the identification of compounds with antiarenaviral activity that could serve as probes to identify arenavirus-host interactions suitable for targeting, as well as lead compounds to develop future antiarenaviral drugs. Screening of a combinatorial library of Krönhke pyridines identified compound KP-146 [(5-(5-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)-4′-methoxy-[1,1′-biphenyl]-3-yl)thiophene-2-carboxamide] as having strong anti-lymphocytic choriomeningitis virus (LCMV) activity in cultured cells. KP-146 did not inhibit LCMV cell entry but rather interfered with the activity of the LCMV ribonucleoprotein (vRNP) responsible for directing virus RNA replication and gene transcription, as well as with the budding process mediated by the LCMV matrix Z protein. LCMV variants with increased resistance to KP-146 did not emerge after serial passages in the presence of KP-146. Our findings support the consideration of Kröhnke pyridine scaffold as a valuable source to identify compounds that could serve as tools to dissect arenavirus-host interactions, as well as lead candidate structures to develop antiarenaviral drugs., This research was supported by NIH/NIAID grants AI047140 and AI077719 to J.C.d.l.T. P.O.M. was supported by a fellowship from the European Union’s Seventh Framework Program FP7/2007-2013 under REA Grant Agreement No.623155., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Direct Access to 2,3,4,6-Tetrasubstituted Tetrahydro-2H-pyrans via Tandem SN2′–Prins Cyclization

  • Scoccia, Jimena
  • Pérez, Sixto J.
  • Sinka, Victoria
  • Cruz, Daniel A.
  • López-Soria, Juan M.
  • Fernández, Israel
  • Martín, Víctor S.
  • Miranda, Pedro O.
  • Padrón, Juan I.
A new, direct, and diastereoselective synthesis of activated 2,3,4,6-tetrasubstituted tetrahydro-2H-pyrans is described. In this reaction, iron(III) catalyzed an SN2′–Prins cyclization tandem process leading to the creation of three new stereocenters in one single step. These activated tetrahydro-2H-pyran units are easily derivatizable through CuAAC conjugations in order to generate multifunctionalized complex molecules. DFT calculations support the in situ SN2′ reaction as a preliminary step in the Prins cyclization., This research was supported by the Spanish MINECO, co-financed by the European Regional Development Fund (ERDF) (CTQ2014- 56362-C2-1-P) and MINECO-FEDER (CTQ2016-78205-P and CTQ2014-51912-REDC to I. F). D. A. C thanks the Spanish MINECO for an F.P.I fellowship. J. M. L-S thanks the Canary Island Government (ACIISI) for a pre-doctoral contract. P. O. M was supported by a Marie Curie IOF from the European Union’s Seventh Framework Program FP7/2007-2013 under REA Grant Agreement No. 623155., Peer Reviewed